Future directions of acute ischaemic stroke therapy
- 1 July 2015
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 14 (7), 758-767
- https://doi.org/10.1016/s1474-4422(15)00054-x
Abstract
No abstract availableThis publication has 82 references indexed in Scilit:
- Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisThe Lancet, 2012
- The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialLancet, 2012
- The immunology of stroke: from mechanisms to translationNature Medicine, 2011
- Greater effect of stroke thrombolysis in the presence of arterial obstructionAnnals of Neurology, 2011
- Annexin A2Stroke, 2010
- Phase IIB/III Trial of Tenecteplase in Acute Ischemic StrokeStroke, 2010
- Annexin A2 Combined with Low-Dose tPA Improves Thrombolytic Therapy in a Rat Model of Focal Embolic StrokeJournal of Cerebral Blood Flow & Metabolism, 2010
- MRI-Based Selection for Intra-Arterial Stroke TherapyStroke, 2009
- Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled studyThe Lancet Neurology, 2009
- A Brief Prehospital Stroke Severity Scale Identifies Ischemic Stroke Patients Harboring Persisting Large Arterial OcclusionsStroke, 2008